首页> 外文会议>World Congress for Microcirculation >Naringenin Exerts Its Anti-Tumor Effect Via Antiangiogenesis
【24h】

Naringenin Exerts Its Anti-Tumor Effect Via Antiangiogenesis

机译:Naringenin通过抗脑发生施加抗肿瘤作用

获取原文

摘要

Naringenin inhibited the proliferation and induced apoptosis in human non-small cell lung carcinoma (A549) cells and human umbilical vein en-dothelial (ECV304) cells. The development of microvessel structures in ECV304 cells and VEGF mRNA expression were inhibited by naringenin in a dose-dependent manner. Naringenin was also able to prevent A549 cell migration and invasion in vitro and to inhibit Lewis Lung Carcinoma (LLC) growth in the subcutaneous mouse model. Naringenin (4,5,7-trihydroxyflavanone), a natural predominant flavanone, has a wide range of pharmacology properties, such as anticancer [1], anti-mutagenic [2], and anti-inflammatory [3]. However, its mechanisms by which inhibits tumor growth remain unclear. Here, we report for the first time that naringenin exerts its anti-tumor effect by the inhibition of angiogenesis.
机译:Naringenin抑制人非小细胞肺癌(A549)细胞和人脐静脉栓塞(ECV304)细胞的增殖和诱导的细胞凋亡。纳林尼以剂量依赖性方式抑制ECV304细胞和VEGF mRNA表达中的微血管结构的发展。 Naringenin还能够在体外预防A549细胞迁移和侵袭,并抑制皮下小鼠模型中的Lewis肺癌(LLC)生长。 Naringenin(4,5,7- TrihydroxyFlavanone),一种自然优势黄酮,具有广泛的药理学性质,如抗癌[1],抗诱变[2]和抗炎[3]。然而,其通过抑制肿瘤生长的机制仍然不清楚。在这里,我们首次报告纳林宁抑制血管生成的抗肿瘤作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号